PET imaging demonstrated rapid tracer uptake in the PD-L1-positive tumor, whereas the PD-L1-negative control tumor showed little tracer retention; the conclusion was that affibody ligands can be effective for in vivo PD-L1 imaging [39]. This evidence concerns the gene CD274 and neoplasm.